Answers are grounded in this paper and cite their sources.
Personalized medicine faces many challenges and barriers before it can be successfully implemented in health systems. The translation of PM to European countries, differences in regulations, high costs of new technologies, and reimbursement are the reasons for the delay in PM implementation.
No takes yet. Share an insight, caveat, or question.
Stefanicka-Wojtas et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: